We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Remdesivir should be part of the “first wave” of efforts to expedite COVID-19 treatments and vaccines, the members of Scientists to Stop COVID-19 said in a plan submitted to the White House. Read More
Challenge studies for COVID-19 vaccines are “incomprehensible” as long as there are safer alternatives, Generex CEO Joe Moscato said yesterday, responding to a letter from lawmakers last week on the subject. Read More
A New York healthcare network is studying famotidine, the active ingredient in the heartburn drug Pepcid, as a potential treatment for COVID-19. Read More
Sanofi and Regeneron have modified their clinical trial of the rheumatoid arthritis drug Kevzara (sarilumab) as a COVID-19 treatment after preliminary results found no benefit in one group. Read More
In a letter to the FDA last week, 35 federal lawmakers recommend the agency consider approving human “challenge” trials for COVID-19, which would infect healthy volunteers with the deadly virus to test efficacy of a vaccine. But the FDA and some researchers have expressed concern over the ethics involved. Read More